Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase M10.013: matrix metallopeptidase-13

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: A Assay, S Structure, T Target, P Specificity, K Knockout, E Expression, V Review, M Mutation, R Splicing, I Inhibitor, L Localization. To select only the references relevant to a single topic, click the link above. See explanation.)

    2024
  1. Dibdiakova,K., Majercikova,Z., Galanda,T., Richterova,R., Kolarovszki,B., Racay,P. and Hatok,J.
    Relationship between the Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Brain Tumors
    Int J Mol Sci25, PubMed  Europe PubMed DOI
  2. Duncan,H.F., Kobayashi,Y., Yamauchi,Y. and Shimizu,E.
    The Reparative Function of MMP13 in Tertiary Reactionary Dentinogenesis after Tooth Injury
    Int J Mol Sci25, PubMed  Europe PubMed DOI
  3. Gao,X., Gao,L.F., Zhang,Z.Y., Jia,S. and Meng,C.Y.
    miR-99b-3p/Mmp13 axis regulates NLRP3 inflammasome-dependent microglial pyroptosis and alleviates neuropathic pain via the promotion of autophagy
    Int Immunopharmacol126, 111331-111331. PubMed  Europe PubMed DOI  K
  4. Hamm,P., Meinel,L. and Driessen,M.D.
    An Introductory Guide to Protease Sensitive Linker Design Using Matrix Metalloproteinase 13 as an Example
    ACS Biomater Sci Eng PubMed  Europe PubMed DOI
  5. Mastalier Manolescu,B.S., Lazar,A.M., Tiplica,G.S., Zurac,S.A., Rebosapca,A., Andreescu,B. and Popp,C.G.
    MMP1, MMP9, MMP11 and MMP13 in melanoma and its metastasis - key points in understanding the mechanisms and celerity of tumor dissemination
    Rom J Morphol Embryol65, 45-52. PubMed  Europe PubMed DOI
  6. Wang,Y.
    Novel drug discovery approaches for MMP-13 inhibitors in the treatment of osteoarthritis
    Bioorg Med Chem Lett114, 130009-130009. PubMed  Europe PubMed DOI
    7. 2023
  7. Cuffaro,D., Gimeno,A., Bernardoni,B.L., Di Leo,R., Pujadas,G., Garcia-Vallve,S., Nencetti,S., Rossello,A. and Nuti,E.
    Identification of N-Acyl Hydrazones as New Non-Zinc-Binding MMP-13 Inhibitors by Structure-Based Virtual Screening Studies and Chemical Optimization
    Int J Mol Sci24, PubMed  Europe PubMed DOI
  8. Gonzalez-Zamora,J., Hernandez,M., Recalde,S., Bezunartea,J., Montoliu,A., Bilbao-Malave,V., Llorente-Gonzalez,S., Garcia-Layana,A. and Fernandez-Robredo,P.
    Matrix Metalloproteinase 13 Is Associated with Age-Related Choroidal Neovascularization
    Antioxidants (Basel)12, PubMed  Europe PubMed DOI
    9. 2022
  9. Gomathi,K., Rohini,M., Vairamani,M. and Selvamurugan,N.
    Identification and characterization of TGF-beta1-responsive Runx2 acetylation sites for matrix Metalloproteinase-13 expression in osteoblastic cells
    Biochimie201, 1-6. PubMed  Europe PubMed DOI
  10. Inagaki,J., Nakano,A., Hatipoglu,O.F., Ooka,Y., Tani,Y., Miki,A., Ikemura,K., Opoku,G., Ando,R., Kodama,S., Ohtsuki,T., Yamaji,H., Yamamoto,S., Katsuyama,E., Watanabe,S. and Hirohata,S.
    Potential of a Novel Chemical Compound Targeting Matrix Metalloprotease-13 for Early Osteoarthritis: An In Vitro Study
    Int J Mol Sci23, PubMed  Europe PubMed DOI
  11. Li,S., Pritchard,D.M. and Yu,L.G.
    Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis
    Cancers (Basel)14, PubMed  Europe PubMed DOI  V
  12. Ponte,F., Kim,H.N., Warren,A., Iyer,S., Han,L., Mannen,E., Gomez-Acevedo,H., Nookaew,I., Almeida,M. and Manolagas,S.C.
    Mmp13 deletion in mesenchymal cells increases bone mass and may attenuate the cortical bone loss caused by estrogen deficiency
    Sci Rep12, 10257-10257. PubMed  Europe PubMed DOI
  13. Smith,S.S., Chu,D., Qu,T., Aggleton,J.A. and Schneider,R.A.
    Species-specific sensitivity to TGFbeta signaling and changes to the Mmp13 promoter underlie avian jaw development and evolution
    elife11, PubMed  Europe PubMed DOI
  14. Tang,K., Wu,Z., Sun,M., Huang,X., Sun,J., Shi,J., Wang,X., Miao,Z., Gao,P., Song,Y. and Wang,Z.
    Elevated MMP10/13 mediated barrier disruption and NF-kappaB activation aggravate colitis and colon tumorigenesis in both individual or full miR-148/152 family knockout mice
    Cancer Lett529, 53-69. PubMed  Europe PubMed DOI
  15. Wilkinson,D.J., Falconer,A.M.D., Wright,H.L., Lin,H., Yamamoto,K., Cheung,K., Charlton,S.H., Arques,M.D.C., Janciauskiene,S., Refaie,R., Rankin,K.S., Young,D.A. and Rowan,A.D.
    Matrix metalloproteinase-13 is fully activated by neutrophil elastase and inactivates its serpin inhibitor, alpha-1 antitrypsin: Implications for osteoarthritis
    FEBS J289, 121-139. PubMed  Europe PubMed
  16. Zhang,X., Ma,L., Shen,Y., Zhang,C., Hou,B. and Zhou,Y.
    Transcription factor paired related homeobox 1 (PRRX1) activates matrix metalloproteinases (MMP)13, which promotes the dextran sulfate sodium-induced inflammation and barrier dysfunction of NCM460 cells
    Bioengineered13, 645-654. PubMed  Europe PubMed DOI  K
  17. Zhang,Y., Li,Z., He,Y., Liu,Y., Mi,G. and Chen,J.
    T-2 toxin induces articular cartilage damage by increasing the expression of MMP-13 via the TGF-beta receptor pathway
    Hum Exp Toxicol41, 9603271221075555-9603271221075555. PubMed  Europe PubMed DOI
    18. 2021
  18. Furlan,A.G., Spanou,C.E.S., Godwin,A.R.F., Wohl,A.P., Zimmermann,L.A., Imhof,T., Koch,M., Baldock,C. and Sengle,G.
    A new MMP-mediated prodomain cleavage mechanism to activate bone morphogenetic proteins from the extracellular matrix
    FASEB J35, e21353-e21353. PubMed  Europe PubMed DOI
  19. Hu,Q. and Ecker,M.
    Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis
    Int J Mol Sci22, 1742-1742. PubMed  Europe PubMed DOI  V
  20. Laghezza,A., Piemontese,L., Brunetti,L., Caradonna,A., Agamennone,M., Loiodice,F. and Tortorella,P.
    (2-Aminobenzothiazole)-Methyl-1,1-Bisphosphonic Acids: Targeting Matrix Metalloproteinase 13 Inhibition to the Bone
    Pharmaceuticals (Basel)14, PubMed  Europe PubMed DOI  I
  21. Liang,D. and Zhang,Z.
    MicroRNA-27b-3p inhibits the proliferation and invasion of cutaneous squamous cell carcinoma by targeting EGFR and MMP-13
    Oncol Lett22, 729-729. PubMed  Europe PubMed DOI
  22. Park,J.Y., Bae,H.C., Pyo,S.H., Lee,M.C. and Han,H.S.
    TGFbeta1-Induced Transglutaminase-2 Triggers Catabolic Response in Osteoarthritic Chondrocytes by Modulating MMP-13
    Tissue Eng Regen Med18, 831-840. PubMed  Europe PubMed DOI
  23. Taylor,S.J., Abeywardane,A., Liang,S., Xiong,Z., Proudfoot,J.R., Farmer,B.S., Gao,D.A., Heim-Riether,A., Smith-Keenan,L.L., Muegge,I., Yu,Y., Zhang,Q., Souza,D., Panzenbeck,M., Goldberg,D., Hill-Drzewi,M., Margarit,M., Collins,B., Li,J.X., Zuvela-Jelaska,L., Li,J. and Farrow,N.A.
    Indole Inhibitors of MMP-13 for Arthritic Disorders
    ACS Omega6, 18635-18650. PubMed  Europe PubMed DOI  I
  24. Zapico,J.M., Acosta,L., Pastor,M., Rangasamy,L., Marquez-Cantudo,L., Coderch,C., Ortin,I., Nicolau-Sanus,M., Puchades-Carrasco,L., Pineda-Lucena,A., Majali-Martinez,A., Ramos,P., de Pascual-Teresa,B. and Ramos,A.
    Design and Synthesis of Water-Soluble and Potent MMP-13 Inhibitors with Activity in Human Osteosarcoma Cells
    Int J Mol Sci22, 9976-9976. PubMed  Europe PubMed DOI  I
    25. 2020
  25. Carreca,A.P., Pravata,V.M., Markham,M., Bonelli,S., Murphy,G., Nagase,H., Troeberg,L. and Scilabra,S.D.
    TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1
    Sci Rep10, 12067-12067. PubMed  Europe PubMed DOI
  26. El Ashry,E.S.H., Awad,L.F., Teleb,M., Ibrahim,N.A., Abu-Serie,M.M. and Abd Al Moaty,M.N.
    Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology
    Bioorg Chem96, 103616-103616. PubMed  Europe PubMed DOI  I
  27. Fields,G., Knapinska,A.M., Singh,C., Drotleff,G., Blanco,D., Chai,C., Schwab,J. and Herd,A.
    Matrix Metalloproteinase 13 Inhibitors for Modulation of Osteoclastogenesis: Enhancement of Solubility and Stability
    ChemMedChem PubMed  Europe PubMed DOI  I
  28. Guimaraes-Stabili,M.R., de Medeiros,M.C., Rossi,D., Camilli,A.C., Zanelli,C.F., Valentini,S.R., Spolidorio,L.C., Kirkwood,K.L. and Rossa,C., Jr.
    Silencing matrix metalloproteinase-13 (Mmp-13) reduces inflammatory bone resorption associated with LPS-induced periodontal disease in vivo
    Clin Oral Investig25, 3161-3172. PubMed  Europe PubMed DOI
  29. Howes,J.M., Knauper,V., Malcor,J.D. and Farndale,R.W.
    Cleavage by MMP-13 renders VWF unable to bind to collagen but increases its platelet reactivity
    J Thromb Haemost18, 942-954. PubMed  Europe PubMed DOI
  30. Lan,Q., Lu,R., Chen,H., Pang,Y., Xiong,F., Shen,C., Qin,Z., Zheng,L., Xu,G. and Zhao,J.
    MMP-13 enzyme and pH responsive theranostic nanoplatform for osteoarthritis
    J Nanobiotechnology18, 117-117. PubMed  Europe PubMed DOI
  31. Li,L., Zhang,J. and Akimenko,M.A.
    Inhibition of mmp13a during zebrafish fin regeneration disrupts fin growth, osteoblasts differentiation, and laminin organization
    Dev Dyn249, 187-198. PubMed  Europe PubMed DOI  K
  32. Moffitt,L.R., Bilandzic,M., Wilson,A.L., Chen,Y., Gorrell,M.D., Oehler,M.K., Plebanski,M. and Stephens,A.N.
    Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells
    Int J Mol Sci21, PubMed  Europe PubMed DOI
  33. Roy,H.S., Dubey,G., Sharma,V.K., Bharatam,P.V. and Ghosh,D.
    Molecular docking and molecular dynamics to identify collagenase inhibitors as lead compounds to address osteoarthritis
    J Biomol Struct Dyn1-13. PubMed  Europe PubMed DOI  I
  34. Small,C.D., El-Khoury,M., Deslongchamps,G., Benfey,T.J. and Crawford,B.D.
    Matrix metalloproteinase 13 activity is required for normal and hypoxia-induced precocious hatching in zebrafish embryos
    J Dev Biol8, 3-3. PubMed  Europe PubMed DOI
    35. 2019
  35. Gall,F.M., Hohl,D., Frasson,D., Wermelinger,T., Mittl,P.R.E., Sievers,M. and Riedl,R.
    Drug design inspired by nature: crystallographic detection of an auto-tailored protease inhibitor template
    Angew Chem Int Ed Engl58, 4051-4055. PubMed  Europe PubMed DOI  I
  36. Huang,S., Feng,K. and Ren,Y.
    Molecular modelling studies of quinazolinone derivatives as MMP-13 inhibitors by QSAR, molecular docking and molecular dynamics simulations techniques
    MedChemComm10, 101-115. PubMed  Europe PubMed DOI  I
  37. Paumier,J.M. and Thinakaran,G.
    Matrix metalloproteinase 13, a new target for therapy in Alzheimer's disease
    Genes Dis6, 1-2. PubMed  Europe PubMed DOI  T
  38. Satish Kumar,K., Velayutham,R. and Roy,K.K.
    A systematic computational analysis of human matrix metalloproteinase 13 (MMP-13) crystal structures and structure-based identification of prospective drug candidates as MMP-13 inhibitors repurposable for osteoarthritis
    J Biomol Struct Dyn1-13. PubMed  Europe PubMed DOI  S  I
  39. Seidl,C.I., Fulga,T.A. and Murphy,C.L.
    CRISPR-Cas9 targeting of MMP13 in human chondrocytes leads to significantly reduced levels of the metalloproteinase and enhanced type II collagen accumulation
    Osteoarthritis Cartilage27, 140-147. PubMed  Europe PubMed DOI
  40. Zhu,B.L., Long,Y., Luo,W., Yan,Z., Lai,Y.J., Zhao,L.G., Zhou,W.H., Wang,Y.J., Shen,L.L., Liu,L., Deng,X.J., Wang,X.F., Sun,F. and Chen,G.J.
    MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation
    Brain142, 176-192. PubMed  Europe PubMed DOI  I
    41. 2018
  41. Fuerst,R., Yong Choi,J., Knapinska,A.M., Smith,L., Cameron,M.D., Ruiz,C., Fields,G.B. and Roush,W.R.
    Development of matrix metalloproteinase-13 inhibitors - a structure-activity/structure-property relationship study
    Bioorg Med Chem26, 4984-4995. PubMed  Europe PubMed DOI  I
  42. Wan,Y., Li,W., Liao,Z., Yan,M., Chen,X. and Tang,Z.
    Selective MMP-13 inhibitors: promising agents for the therapy of osteoarthritis
    Curr Med Chem27, 3753-3769. PubMed  Europe PubMed DOI  I
    43. 2017
  43. Choi,J.Y., Fuerst,R., Knapinska,A.M., Taylor,A.B., Smith,L., Cao,X., Hart,P.J., Fields,G.B. and Roush,W.R.
    Structure-based design and synthesis of potent and selective matrix metalloproteinase 13 inhibitors
    J Med Chem60, 5816-5825. PubMed  Europe PubMed DOI  I
  44. Choi,J.Y. and Fuerst,R.
    Virtual high-throughput screening for matrix metalloproteinase inhibitors
    Methods Mol Biol1579, 259-271. PubMed  Europe PubMed DOI  I
  45. Fischer,T. and Riedl,R.
    Targeted fluoro positioning for the discovery of a potent and highly selective matrix metalloproteinase inhibitor
    ChemistryOpen6, 167- PubMed  Europe PubMed DOI  I
  46. Hugenberg,V., Wagner,S., Kopka,K., Schafers,M., Schuit,R.C., Windhorst,A.D. and Hermann,S.
    Radiolabeled selective matrix metalloproteinase 13 (MMP-13) inhibitors: (radio)syntheses and in vitro and first in vivo evaluation
    J Med Chem60, 307-321. PubMed  Europe PubMed DOI  I
  47. Inanc,S., Keles,D. and Oktay,G.
    An improved collagen zymography approach for evaluating the collagenases MMP-1, MMP-8, and MMP-13
    Biotechniques63, 174-180. PubMed  Europe PubMed DOI  L
  48. Nara,H., Kaieda,A., Sato,K., Naito,T., Mototani,H., Oki,H., Yamamoto,Y., Kuno,H., Santou,T., Kanzaki,N., Terauchi,J., Uchikawa,O. and Kori,M.
    Discovery of novel, highly potent, and selective matrix metalloproteinase (MMP)-13 inhibitors with a 1,2,4-triazol-3-yl moiety as a zinc binding group using a structure-based design approach
    J Med Chem60, 608-626. PubMed  Europe PubMed DOI  I
  49. Ramezani,M. and Shamsara,J.
    Virtual screening on MMP-13 led to discovering new inhibitors including a non-zinc binding and a micro molar one: a successful example of receptor selection according to cross-docking results for a flexible enzyme
    Comb Chem High Throughput Screen20, 719-725. PubMed  Europe PubMed DOI  I
  50. Xie,X.W., Wan,R.Z. and Liu,Z.P.
    Recent research advances in selective matrix metalloproteinase-13 inhibitors as anti-osteoarthritis agents
    ChemMedChem12, 1157-1168. PubMed  Europe PubMed DOI  V  I
    51. 2016
  51. Bartmann,J., Frankenberger,M., Neurohr,C., Eickelberg,O., Noessner,E. and von Wulffen,W.
    A novel role of MMP-13 for murine DC function: its inhibition dampens T-cell activation
    Int Immunol28, 473-487. PubMed  Europe PubMed DOI  I
  52. Fischer,T. and Riedl,R.
    Molecular recognition of the catalytic zinc(II) ion in MMP-13: structure-based evolution of an allosteric inhibitor to dual binding mode inhibitors with improved lipophilic ligand efficiencies
    Int J Mol Sci17, 314-314. PubMed  Europe PubMed DOI  I
  53. Nakatani,T., Chen,T. and Partridge,N.C.
    MMP-13 is one of the critical mediators of the effect of HDAC4 deletion on the skeleton
    Bone90, 142-151. PubMed  Europe PubMed DOI
  54. Nara,H., Sato,K., Kaieda,A., Oki,H., Kuno,H., Santou,T., Kanzaki,N., Terauchi,J., Uchikawa,O. and Kori,M.
    Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors
    Bioorg Med Chem24, 6149-6165. PubMed  Europe PubMed DOI  I
  55. Nirmala,G., Adimulam,Y.B. and Seetharamaiah,P.
    Computational molecular docking and structural specificity of bipyrazoles as non-zinc chelating inhibitors of MMP-13
    Int J Comp Biol Drug Des9, 162-171. DOI  I
  56. Pizio,A.D., Agamennone,M. and Tortorella,P.
    Non-zinc-binding inhibitors of MMP-13: GRID-based approaches to rationalize the binding process
    Curr Top Med Chem16, 449-459. PubMed  Europe PubMed  S  I
  57. Ruminski,P.G., Massa,M., Strohbach,J., Hanau,C.E., Schmidt,M., Scholten,J.A., Fletcher,T.R., Hamper,B.C., Carroll,J.N., Shieh,H.S., Caspers,N., Collins,B., Grapperhaus,M., Palmquist,K.E., Collins,J., Baldus,J.E., Hitchcock,J., Kleine,H.P., Rogers,M.D., McDonald,J., Munie,G.E., Messing,D.M., Portolan,S., Whiteley,L.O., Sunyer,T. and Schnute,M.E.
    Discovery of N-(4-fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-14-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A highly selective and orally bioavailable matrix metalloproteinase-13 inhibitor for the potential treatment of osteoarthritis
    J Med Chem59, 313-327. PubMed  Europe PubMed DOI  I
  58. Shamsara,J.
    Considering rotatability of hydroxyl groups for the active site residues of MMP-13 in retrospective virtual screening campaigns
    Open Med Chem J10, 1-6. PubMed  Europe PubMed DOI
  59. Wen,H., Qin,Y., Zhong,W., Li,C., Liu,X. and Shen,Y.
    Trivalent metal ions based on inorganic compounds with in vitro inhibitory activity of matrix metalloproteinase 13
    Enzyme Microb Technol92, 9-17. PubMed  Europe PubMed DOI  I
  60. Zhang,X., Wang,J., Liu,M., Wang,S., Zhang,H. and Zhao,Y.
    Cloning, expression, purification, and characterization of the catalytic domain of sika deer MMP-13
    Protein Expr Purif127, 16-21. PubMed  Europe PubMed DOI
    61. 2015
  61. Bhowmick,M., Stawikowska,R., Tokmina-Roszyk,D. and Fields,G.B.
    Matrix metalloproteinase inhibition by heterotrimeric triple-helical peptide transition state analogues
    Chembiochem16, 1084-1092. PubMed  Europe PubMed DOI  I
  62. Santamaria,S., Nuti,E., Cercignani,G., La Regina,G., Silvestri,R., Supuran,C.T. and Rossello,A.
    Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors
    J Enzyme Inhib Med Chem30, 947-954. PubMed  Europe PubMed DOI  I
  63. Shih,C.L. and Ajuwon,K.M.
    Inhibition of MMP-13 prevents diet-induced obesity in mice and suppresses adipogenesis in 3T3-L1 preadipocytes
    Mol Biol Rep42, 1225-1232. PubMed  Europe PubMed DOI  I
  64. Stawikowski,M.J., Stawikowska,R. and Fields,G.B.
    Collagenolytic matrix metalloproteinase activities toward peptomeric triple-helical substrates
    Biochemistry54, 3110-3121. PubMed  Europe PubMed DOI  P
  65. Wang,W., Zeng,L., Wang,Z.M., Zhang,S., Rong,X.F. and Li,R.H.
    Ginsenoside Rb1 inhibits matrix metalloproteinase 13 through down-regulating Notch signaling pathway in osteoarthritis
    Exp Biol Med (Maywood)240, 1614-1621. PubMed  Europe PubMed DOI
  66. Yu,X., Wei,F., Yu,J., Zhao,H., Jia,L., Ye,Y., Du,R., Ren,X. and Li,H.
    Matrix metalloproteinase 13: a potential intermediate between low expression of microRNA-125b and increasing metastatic potential of non-small cell lung cancer
    Cancer Genet208, 76-84. PubMed  Europe PubMed DOI
  67. Zhang,R., Zhang,L., Li,C., Chen,B., Li,Q., Fang,X. and Shen,Y.
    Refolding of recombinant histidine-tagged catalytic domain of MMP-13 from Escherichia coli with ion-exchange chromatography for higher bioactivity
    J Liq Chromatogr Relat Technol38, 561-568. DOI  E
    68. 2014
  68. Akagi,R., Sasho,T., Saito,M., Endo,J., Yamaguchi,S., Muramatsu,Y., Mukoyama,S., Akatsu,Y., Katsuragi,J., Fukawa,T. and Takahashi,K.
    Effective knock down of matrix metalloproteinase-13 by an intra-articular injection of small interfering RNA (siRNA) in a murine surgically-induced osteoarthritis model
    J Orthop Res32, 1175-1180. PubMed  Europe PubMed DOI  K
  69. Bonaf‚,L., Liang,J., Gorna,M.W., Zhang,Q., Ha-Vinh,R., Campos-Xavier,A.B., Unger,S., Beckmann,J.S., Le,B.c.A., Stevenson,B., Giedion,A., Liu,X., Superti-Furga,G., Wang,W., Spahr,A. and Superti-Furga,A.
    MMP13 mutations are the cause of recessive metaphyseal dysplasia, Spahr type
    Am J Med Genet A164A, 1175-1179. PubMed  Europe PubMed
  70. Gao,P., Yang,J.-L., Zhao,H., You,J.-H. and Hu,Y.
    Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis
    Tumour Biol35, 10137-10148. PubMed  Europe PubMed DOI  M
  71. Howes,J.M., Bihan,D., Slatter,D.A., Hamaia,S.W., Packman,L.C., Knauper,V., Visse,R. and Farndale,R.W.
    The recognition of collagen and triple-helical Toolkit peptides by MMP-13: sequence specificity for binding and cleavage
    J Biol Chem289, 24091-24101. PubMed  Europe PubMed DOI  P
  72. Iwao,Y., Shiga,K., Shiroshita,A., Yoshikawa,T., Sakiie,M., Ueno,T., Ueno,S., Ijiri,T.W. and Sato,K.-I.
    The need of MMP-2 on the sperm surface for Xenopus fertilization: its role in a fast electrical block to polyspermy
    Mech Dev134, 80-95. PubMed  Europe PubMed DOI
  73. Joo,N.E., Miao,D., Bermudez,M., Stallcup,W.B. and Kapila,Y.L.
    Shedding of NG2 by MMP-13 attenuates anoikis
    DNA Cell Biol33, 854-862. PubMed  Europe PubMed DOI
  74. Li,B.-K., Cong,Y., Tian,Z.-Y. and Xue,Y.
    Predicting and virtually screening the selective inhibitors of MMP-13 over MMP-1 by molecular descriptors and machine learning methods
    Wuli Huaxue Xuebao Acta Phys Chim Sin30, 171-182. DOI  I
  75. Li,C., Zhang,R., Chen,B., Li,Q., Fang,X. and Shen,Y.
    Purification of recombinant histidine-tagged catalytic domain of MMP-13 in one-step using affinity column and renaturation of it with histidine-tag
    J Liq Chromatogr Relat Technol37, 2118-2130. DOI  E
  76. Lim,N.H., Meinjohanns,E., Bou-Gharios,G., Gompels,L.L., Nuti,E., Rossello,A., Devel,L., Dive,V., Meldal,M. and Nagase,H.
    In vivo imaging of matrix metalloproteinase 12 and matrix metalloproteinase 13 activities in the mouse model of collagen-induced arthritis
    Arthritis Rheum66, 589-598. PubMed  Europe PubMed DOI  L  I
  77. Meides,A., Gutschalk,C.M., Devel,L., Beau,F., Czarny,B., Hensler,S., Neugebauer,J., Dive,V., Angel,P. and Mueller,M.M.
    Effects of selective MMP-13 inhibition in squamous cell carcinoma depend on estrogen
    Int J Cancer135, 2749-2759. PubMed  Europe PubMed DOI  I
  78. Nara,H., Sato,K., Naito,T., Mototani,H., Oki,H., Yamamoto,Y., Kuno,H., Santou,T., Kanzaki,N., Terauchi,J., Uchikawa,O. and Kori,M.
    Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1'' binding site
    Bioorg Med Chem22, 5487-5505. PubMed  Europe PubMed DOI  I
  79. Nara,H., Sato,K., Naito,T., Mototani,H., Oki,H., Yamamoto,Y., Kuno,H., Santou,T., Kanzaki,N., Terauchi,J., Uchikawa,O. and Kori,M.
    Discovery of novel, highly potent, and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without a zinc binding group using a structure-based design approach
    J Med Chem57, 8886-8902. PubMed  Europe PubMed DOI  I
  80. Spicer,T.P., Jiang,J., Taylor,A.B., Choi,J.Y., Hart,P.J., Roush,W.R., Fields,G.B., Hodder,P.S. and Minond,D.
    Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro
    J Med Chem57, 9598-9611. PubMed  Europe PubMed DOI  I
  81. Xi,L., Li,S., Yao,X., Wei,Y., Li,J., Liu,H. and Wu,X.
    In silico study combining docking and QSAR methods on a series of matrix metalloproteinase 13 inhibitors
    Arch Pharm (Weinheim)347, 825-833. PubMed  Europe PubMed DOI  I
  82. Zhu,L., Ma,Y., Kiesewetter,D.O., Wang,Y., Lang,L., Lee,S., Niu,G. and Chen,X.
    Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity
    ACS Chem Biol9, 510-516. PubMed  Europe PubMed DOI  L
    83. 2013
  83. Fischer,T. and Riedl,R.
    Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors
    ChemMedChem8, 1457-1461. PubMed  Europe PubMed DOI  I
  84. Hugenberg,V., Riemann,B., Hermann,S., Schober,O., Schafers,M., Szardenings,K., Lebedev,A., Gangadharmath,U., Kolb,H., Walsh,J., Zhang,W., Kopka,K. and Wagner,S.
    Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (Radio)synthesis, in vitro and first in vivo evaluation
    J Med Chem56, 6858-6870. PubMed  Europe PubMed DOI  I
  85. Kalva,S., Saranyah,K., Suganya,P.R., Nisha,M. and Saleena,L.M.
    Potent inhibitors precise to S1' loop of MMP-13, a crucial target for osteoarthritis
    J Mol Graph Model44, 297-310. PubMed  Europe PubMed DOI  I
  86. Lei,H., Leong,D., Smith,L.R. and Barton,E.R.
    Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration
    Am J Physiol Cell Physiol305, C529-C538. PubMed  Europe PubMed DOI
  87. Li,N.G., Tang,Y.P. and Duan,J.A.
    New selective inhibitors of MMP-13 for inflammatory diseases: a patent evaluation (W02012151158)
    Expert Opin Ther Pat23, 669-675. PubMed  Europe PubMed DOI  I
  88. Lu,H.B., Wang,S.H., Li,Q.M. and Wang,Y.S.
    Design, synthesis and evaluation of 6-oxo-1, 6-dihydropyrimidine-2,5-dicarboxamide derivatives as MMP 13 inhibitors
    Chem Res Chin Univ29, 67-70. DOI  I
  89. Miller,R.E., Lu,Y., Tortorella,M.D. and Malfait,A.M.
    Genetically engineered mouse models reveal the importance of proteases as osteoarthritis drug targets
    Curr Rheumatol Rep15, 350-350. PubMed  Europe PubMed DOI  K
  90. Stura,E.A., Visse,R., Cuniasse,P., Dive,V. and Nagase,H.
    Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain
    FASEB J27, 4395-4405. PubMed  Europe PubMed DOI  S
  91. Vandenbroucke,R.E., Dejonckheere,E., Van Hauwermeiren,F., Lodens,S., De Rycke,R., Van Wonterghem,E., Staes,A., Gevaert,K., Lopez-Otin,C. and Libert,C.
    Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF
    EMBO Mol Med5, 932-948. PubMed  Europe PubMed DOI  P
  92. Zhong,H.A., Arbiser,J. and Bowen,J.P.
    Selectivity, binding affinity, and ionization state of matrix metalloproteinase inhibitors
    Curr Pharm Des19, 4701-4713. PubMed  Europe PubMed DOI  I
    93. 2012
  93. Gege,C., Bao,B., Bluhm,H., Boer,J., Gallagher,B.M., Korniski,B., Powers,T.S., Steeneck,C., Taveras,A.G. and Baragi,V.M.
    Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis
    J Med Chem55, 709-716. PubMed  Europe PubMed DOI  I
  94. Henriet,P. and Eeckhout,Y.
    Matrix metallopeptidase-13/collagenase 3
    [ISSN:978-0-12-407744-7]3, 734-744. DOI
  95. La Pietra,V., Marinelli,L., Cosconati,S., Di Leva,F.S., Nuti,E., Santamaria,S., Pugliesi,I., Morelli,M., Casalini,F., Rossello,A., La Motta,C., Taliani,S., Visse,R., Nagase,H., Da Settimo,F. and Novellino,E.
    Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization
    Eur J Med Chem47, 143-152. PubMed  Europe PubMed DOI  I
  96. Naito,S., Takahashi,T., Onoda,J., Yamauchi,A., Kawai,T., Kishino,J., Yamane,S., Fujii,I., Fukui,N. and Numata,Y.
    Development of a neutralizing antibody specific for the active form of matrix metalloproteinase-13
    Biochemistry51, 8877-8884. PubMed  Europe PubMed DOI
  97. Santamaria,S., Nuti,E., Cercignani,G., Marinelli,L., La Pietra,V., Novellino,E. and Rossello,A.
    N-O-Isopropyl sulfonamido-based hydroxamates: kinetic characterisation of a series of MMP-12/MMP-13 dual target inhibitors
    Biochem Pharmacol84, 813-820. PubMed  Europe PubMed DOI  I
  98. Troeberg,L. and Nagase,H.
    Proteases involved in cartilage matrix degradation in osteoarthritis
    Biochim Biophys Acta1824, 133-145. PubMed  Europe PubMed DOI  V
    99. 2011
  99. Barta,T.E., Becker,D.P., Bedell,L.J., Easton,A.M., Hockerman,S.L., Kiefer,J., Munie,G.E., Mathis,K.J., Li,M.H., Rico,J.G., Villamil,C.I. and Williams,J.M.
    MMP-13 selective alpha-sulfone hydroxamates: a survey of P1' heterocyclic amide isosteres
    Bioorg Med Chem Lett21, 2820-2822. PubMed  Europe PubMed DOI  I
  100. Chakrabarti,B., Bairagya,H.R., Mallik,P., Mukhopadhyay,B.P. and Bera,A.K.
    An insight to conserved water molecular dynamics of catalytic and structural Zn(+2) ions in matrix metalloproteinase 13 of human
    J Biomol Struct Dyn28, 503-516. PubMed  Europe PubMed DOI  S
  101. Fobian,Y.M., Freskos,J.N., Barta,T.E., Bedell,L.J., Heintz,R., Kassab,D.J., Kiefer,J.R., Mischke,B.V., Molyneaux,J.M., Mullins,P., Munie,G.E. and Becker,D.P.
    MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides
    Bioorg Med Chem Lett21, 2823-2825. PubMed  Europe PubMed DOI  I
  102. Goldring,M.B., Otero,M., Plumb,D.A., Dragomir,C., Favero,M., El Hachem,H., Hashimoto,K., Roach,H.I., Olivotto,E., Borzi,R.M. and Marcu,K.B.
    Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis
    Eur Cell Mater21, 202-220. PubMed  Europe PubMed
  103. Li,N.G., Shi,Z.H., Tang,Y.P., Wang,Z.J., Song,S.L., Qian,L.H., Qian,D.W. and Duan,J.A.
    New hope for the treatment of osteoarthritis through selective inhibition of MMP-13
    Curr Med Chem18, 977-1001. PubMed  Europe PubMed DOI  I
  104. Mazurek,S.G., Li,J., Nabozny,G.H., Reinhart,G.A., Muthukumarana,A.C., Harrison,P.C. and Fryer,R.M.
    Functional biomarkers of musculoskeletal syndrome (MSS) for early in vivo screening of selective MMP-13 inhibitors
    J Pharmacol Toxicol Methods64, 89-96. PubMed  Europe PubMed DOI  I
  105. Moroy,G., Bourguet,E., Decarme,M., Sapi,J., Alix,A.J., Hornebeck,W. and Lorimier,S.
    Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s)
    Biochem Pharmacol81, 626-635. PubMed  Europe PubMed DOI  I
  106. Quillard,T., Tesmenitsky,Y., Croce,K., Travers,R., Shvartz,E., Koskinas,K.C., Sukhova,G.K., Aikawa,E., Aikawa,M. and Libby,P.
    Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis
    Arterioscler Thromb Vasc Biol31, 2464-2472. PubMed  Europe PubMed DOI  I
  107. Roth,J., Minond,D., Darout,E., Liu,Q., Lauer,J., Hodder,P., Fields,G.B. and Roush,W.R.
    Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds
    Bioorg Med Chem Lett21, 7180-7184. PubMed  Europe PubMed DOI  I
  108. Ryu,J.H., Lee,A., Na,J.H., Lee,S., Ahn,H.J., Park,J.W., Ahn,C.H., Kim,B.S., Kwon,I.C., Choi,K., Youn,I. and Kim,K.
    Optimization of matrix metalloproteinase fluorogenic probes for osteoarthritis imaging
    Amino Acids41, 1113-1122. PubMed  Europe PubMed DOI  A  L
  109. Taylor,S.J., Abeywardane,A., Liang,S., Muegge,I., Padyana,A.K., Xiong,Z., Hill-Drzewi,M., Farmer,B., Li,X., Collins,B., Li,J.X., Heim-Riether,A., Proudfoot,J., Zhang,Q., Goldberg,D., Zuvela-Jelaska,L., Zaher,H., Li,J. and Farrow,N.A.
    Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13
    J Med Chem54, 8174-8187. PubMed  Europe PubMed DOI  I
  110. Tommasi,R.A., Weiler,S., McQuire,L.W., Rogel,O., Chambers,M., Clark,K., Doughty,J., Fang,J., Ganu,V., Grob,J., Goldberg,R., Goldstein,R., Lavoie,S., Kulathila,R., Macchia,W., Melton,R., Springer,C., Walker,M., Zhang,J., Zhu,L. and Shultz,M.
    Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13
    Bioorg Med Chem Lett21, 6440-6445. PubMed  Europe PubMed DOI  I
  111. Vicini,P., Crasci,L., Incerti,M., Ronsisvalle,S., Cardile,V. and Panico,A.M.
    Benzisothiazolyliminothiazolidin-4-ones with chondroprotective properties: searching for potent and selective inhibitors of MMP-13
    ChemMedChem6, 1199-1202. PubMed  Europe PubMed DOI  I
    112. 2010
  112. Becker,D.P., Barta,T.E., Bedell,L.J., Boehm,T.L., Bond,B.R., Carroll,J., Carron,C.P., Decrescenzo,G.A., Easton,A.M., Freskos,J.N., Funckes-Shippy,C.L., Heron,M., Hockerman,S., Howard,C.P., Kiefer,J.R., Li,M.H., Mathis,K.J., McDonald,J.J., Mehta,P.P., Munie,G.E., Sunyer,T., Swearingen,C.A., Villamil,C.I., Welsch,D., Williams,J.M., Yu,Y. and Yao,J.
    Orally active MMP-1 sparing alpha-tetrahydropyranyl and alpha-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease
    J Med Chem53, 6653-6680. PubMed  Europe PubMed DOI  I
  113. Borzi,R.M., Olivotto,E., Pagani,S., Vitellozzi,R., Neri,S., Battistelli,M., Falcieri,E., Facchini,A., Flamigni,F., Penzo,M., Platano,D., Santi,S., Facchini,A. and Marcu,K.B.
    Matrix metalloproteinase 13 loss associated with impaired extracellular matrix remodeling disrupts chondrocyte differentiation by concerted effects on multiple regulatory factors
    Arthritis Rheum62, 2370-2381. PubMed  Europe PubMed DOI  K
  114. Devel,L., Czarny,B., Beau,F., Georgiadis,D., Stura,E. and Dive,V.
    Third generation of matrix metalloprotease inhibitors: gain in selectivity by targeting the depth of the S1' cavity
    Biochimie92, 1501-1508. PubMed  Europe PubMed DOI  I
  115. Flechsig,P., Hartenstein,B., Teurich,S., Dadrich,M., Hauser,K., Abdollahi,A., Grone,H.J., Angel,P. and Huber,P.E.
    Loss of matrix metalloproteinase-13 attenuates murine radiation-induced pulmonary fibrosis
    Int J Radiat Oncol Biol Phys77, 582-590. PubMed  Europe PubMed DOI  K  T
  116. Gao,D.A., Xiong,Z., Heim-Riether,A., Amodeo,L., August,E.M., Cao,X., Ciccarelli,L., Collins,B.K., Harrington,K., Haverty,K., Hill-Drzewi,M., Li,X., Liang,S., Margarit,S.M., Moss,N., Nagaraja,N., Proudfoot,J., Roman,R., Schlyer,S., Keenan,L.S., Taylor,S., Wellenzohn,B., Wiedenmayer,D., Li,J. and Farrow,N.A.
    SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability
    Bioorg Med Chem Lett20, 5039-5043. PubMed  Europe PubMed DOI  I
  117. Inoue,A., Takahashi,H., Harada,H., Kohno,S., Ohue,S., Kobayashi,K., Yano,H., Tanaka,J. and Ohnishi,T.
    Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity
    Int J Oncol37, 1121-1131. PubMed  Europe PubMed DOI
  118. Jiang,Y., Abernathy,J.W., Peatman,E., Liu,H., Wang,S., Xu,D.H., Kucuktas,H., Klesius,P. and Liu,Z.
    Identification and characterization of matrix metalloproteinase-13 sequence structure and expression during embryogenesis and infection in channel catfish (Ictalurus punctatus)
    Dev Comp Immunol34, 590-597. PubMed  Europe PubMed DOI
  119. Jungel,A., Ospelt,C., Lesch,M., Thiel,M., Sunyer,T., Schorr,O., Michel,B.A., Gay,R.E., Kolling,C., Flory,C., Gay,S. and Neidhart,M.
    Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis
    Ann Rheum Dis69, 898-902. PubMed  Europe PubMed DOI  I
  120. Kolodziej,S.A., Hockerman,S.L., Decrescenzo,G.A., McDonald,J.J., Mischke,D.A., Munie,G.E., Fletcher,T.R., Stehle,N., Swearingen,C. and Becker,D.P.
    MMP-13 selective isonipecotamide alpha-sulfone hydroxamates
    Bioorg Med Chem Lett20, 3561-3564. PubMed  Europe PubMed DOI  I
  121. Kothapalli,R., Khan,A.M., Basappa, Gopalsamy,A., Chong,Y.S. and Annamalai,L.
    Cheminformatics-based drug design approach for identification of inhibitors targeting the characteristic residues of MMP-13 hemopexin domain
    PLoS ONE5, e12494-e12494. PubMed  Europe PubMed DOI  I
  122. Piecha,D., Weik,J., Kheil,H., Becher,G., Timmermann,A., Jaworski,A., Burger,M. and Hofmann,M.W.
    Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants
    Inflamm Res59, 379-389. PubMed  Europe PubMed DOI  I
  123. Schnute,M.E., O'Brien,P.M., Nahra,J., Morris,M., Howard Roark,W., Hanau,C.E., Ruminski,P.G., Scholten,J.A., Fletcher,T.R., Hamper,B.C., Carroll,J.N., Patt,W.C., Shieh,H.S., Collins,B., Pavlovsky,A.G., Palmquist,K.E., Aston,K.W., Hitchcock,J., Rogers,M.D., McDonald,J., Johnson,A.R., Munie,G.E., Wittwer,A.J., Man,C.F., Settle,S.L., Nemirovskiy,O., Vickery,L.E., Agawal,A., Dyer,R.D. and Sunyer,T.
    Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Bioorg Med Chem Lett20, 576-580. PubMed  Europe PubMed DOI  I
  124. Sen,A.I., Shiomi,T., Okada,Y. and D'Armiento,J.M.
    Deficiency of matrix metalloproteinase-13 increases inflammation after acute lung injury
    Exp Lung Res36, 615-624. PubMed  Europe PubMed DOI  K
  125. Settle,S., Vickery,L., Nemirovskiy,O., Vidmar,T., Bendele,A., Messing,D., Ruminski,P., Schnute,M. and Sunyer,T.
    Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: confirmation by multivariate analysis that modulation of type II collagen and aggrecan degradation peptides parallels pathologic changes
    Arthritis Rheum62, 3006-3015. PubMed  Europe PubMed DOI  I
  126. Zhang,L., Yang,M., Yang,D., Cavey,G., Davidson,P. and Gibson,G.
    Molecular interactions of MMP-13 C-terminal domain with chondrocyte proteins
    Connect Tissue Res51, 230-239. PubMed  Europe PubMed DOI
    127. 2009
  127. Baragi,V.M., Becher,G., Bendele,A.M., Biesinger,R., Bluhm,H., Boer,J., Deng,H., Dodd,R., Essers,M., Feuerstein,T., Gallagher,B.M., Jr., Gege,C., Hochgurtel,M., Hofmann,M., Jaworski,A., Jin,L., Kiely,A., Korniski,B., Kroth,H., Nix,D., Nolte,B., Piecha,D., Powers,T.S., Richter,F., Schneider,M., Steeneck,C., Sucholeiki,I., Taveras,A., Timmermann,A., Van Veldhuizen,J., Weik,J., Wu,X. and Xia,B.
    A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models
    Arthritis Rheum60, 2008-2018. PubMed  Europe PubMed DOI  I
  128. Carrascal,N. and Rizzo,R.C.
    Calculation of binding free energies for non-zinc chelating pyrimidine dicarboxamide inhibitors with MMP-13
    Bioorg Med Chem Lett19, 47-50. PubMed  Europe PubMed DOI  I
  129. Guo,A., Yang,L. and Gu,J.C.
    Membrane type-1 metalloproteinase mediates nitric oxide-induced activation of matrix metalloproteinase-13
    Orthopedics32, 826-826. PubMed  Europe PubMed DOI
  130. Hattori,N., Mochizuki,S., Kishi,K., Nakajima,T., Takaishi,H., D'Armiento,J. and Okada,Y.
    MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing
    Am J Pathol175, 533-546. PubMed  Europe PubMed DOI  K
  131. Heim-Riether,A., Taylor,S.J., Liang,S., Gao,D.A., Xiong,Z., Michael August,E., Collins,B.K., Farmer,B.T., Haverty,K., Hill-Drzewi,M., Junker,H.D., Mariana Margarit,S., Moss,N., Neumann,T., Proudfoot,J.R., Keenan,L.S., Sekul,R., Zhang,Q., Li,J. and Farrow,N.A.
    Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors
    Bioorg Med Chem Lett19, 5321-5324. PubMed  Europe PubMed DOI  I
  132. Hernández,R.M., Sorsa,T., Obregón,F., Tervahartiala,T., Valenzuela,M.A., zo,P., tzan,N., saffre,E., las,M. and monal,J.
    Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade
    J Clin Periodontol36, 1011-1017. PubMed  Europe PubMed  I
  133. Kulkarni,G.B., Siva Reddy,A., Ramadevi,K., Kezia,D. and Narasimha Rao,M.
    3D-QSAR studies of matrix metalloproteinase-13 inhibitors
    Rasayan J Chem2, 407-414.  I
  134. Lauer-Fields,J.L., Minond,D., Chase,P.S., Baillargeon,P.E., Saldanha,S.A., Stawikowska,R., Hodder,P. and Fields,G.B.
    High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate
    Bioorg Med Chem17, 990-1005. PubMed  Europe PubMed DOI  I
  135. Lausch,E., Keppler,R., Hilbert,K., Cormier-Daire,V., Nikkel,S., Nishimura,G., Unger,S., Spranger,J., Superti-Furga,A. and Zabel,B.
    Mutations in MMP9 and MMP13 determine the mode of inheritance and the clinical spectrum of metaphyseal anadysplasia
    Am J Hum Genet85, 168-178. PubMed  Europe PubMed
  136. Lee,E.R., Lamplugh,L., Kluczyk,B., Leblond,C.P. and Mort,J.S.
    Neoepitopes reveal the features of type II collagen cleavage and the identity of a collagenase involved in the transformation of the epiphyses anlagen in development
    Dev Dyn238, 1547-1563. PubMed  Europe PubMed DOI
  137. Li,W., Hu,Y., Li,J., Thomason,J.R., DeVincentis,D., Du,X., Wu,J., Hotchandani,R., Rush,T.S., III, Skotnicki,J.S., Tam,S., Chockalingam,P.S., Morris,E.A. and Levin,J.I.
    3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding
    Bioorg Med Chem Lett19, 4546-4550. PubMed  Europe PubMed DOI  I
  138. Little,C.B., Barai,A., Burkhardt,D., Smith,S.M., Fosang,A.J., Werb,Z., Shah,M. and Thompson,E.W.
    Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development
    Arthritis Rheum60, 3723-3733. PubMed  Europe PubMed DOI  K
  139. Monovich,L.G., Tommasi,R.A., Fujimoto,R.A., Blancuzzi,V., Clark,K., Cornell,W.D., Doti,R., Doughty,J., Fang,J., Farley,D., Fitt,J., Ganu,V., Goldberg,R., Goldstein,R., Lavoie,S., Kulathila,R., Macchia,W., Parker,D.T., Melton,R., O'Byrne,E., Pastor,G., Pellas,T., Quadros,E., Reel,N., Roland,D.M., Sakane,Y., Singh,H., Skiles,J., Somers,J., Toscano,K., Wigg,A., Zhou,S., Zhu,L., Shieh,W.C., Xue,S. and McQuire,L.W.
    Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13
    J Med Chem52, 3523-3538. PubMed  Europe PubMed DOI  I
  140. Nuti,E., Casalini,F., Avramova,S.I., Santamaria,S., Cercignani,G., Marinelli,L., La Pietra,V., Novellino,E., Orlandini,E., Nencetti,S., Tuccinardi,T., Martinelli,A., Lim,N.H., Visse,R., Nagase,H. and Rossello,A.
    N-O-Isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis
    J Med Chem52, 4757-4773. PubMed  Europe PubMed DOI  I
  141. Yeh,W.L., Lu,D.Y., Lee,M.J. and Fu,W.M.
    Leptin induces migration and invasion of glioma cells through MMP-13 production
    Glia57, 454-464. PubMed  Europe PubMed DOI
  142. Zigrino,P., Kuhn,I., Bauerle,T., Zamek,J., Fox,J.W., Neumann,S., Licht,A., Schorpp-Kistner,M., Angel,P. and Mauch,C.
    Stromal expression of MMP-13 is required for melanoma invasion and metastasis
    J Invest Dermatol129, 2686-2693. PubMed  Europe PubMed DOI  T
    143. 2008
  143. Gooljarsingh,L.T., Lakdawala,A., Coppo,F., Luo,L., Fields,G.B., Tummino,P.J. and Gontarek,R.R.
    Characterization of an exosite binding inhibitor of matrix metalloproteinase 13
    Protein Sci17, 66-71. PubMed  Europe PubMed DOI  I
  144. Lee,S., Park,K., Lee,S.Y., Ryu,J.H., Park,J.W., Ahn,H.J., Kwon,I.C., Youn,I.C., Kim,K. and Choi,K.
    Dark quenched matrix metalloproteinase fluorogenic probe for imaging osteoarthritis development in vivo
    Bioconjug Chem19, 1743-1747. PubMed  Europe PubMed DOI  L
  145. Li,J.J., Nahra,J., Johnson,A.R., Bunker,A., O'Brien,P., Yue,W.S., Ortwine,D.F., Man,C.F., Baragi,V., Kilgore,K., Dyer,R.D. and Han,H.K.
    Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    J Med Chem51, 835-841. PubMed  Europe PubMed DOI  I
  146. Monfort,J., Tardif,G., Roughley,P., Reboul,P., Boileau,C., Bishop,P.N., Pelletier,J.P. and Martel-Pelletier,J.
    Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis
    Osteoarthritis Cartilage16, 749-755. PubMed  Europe PubMed DOI
  147. Yiotakis,A. and Dive,V.
    Third-generation MMP inhibitors: Recent advances in the development of highly selective inhibitors
    The Cancer Degradome: Proteases and Cancer Biol811-825. DOI  I
  148. Yiotakis,A. and Dive,V.
    Synthetic active site-directed inhibitors of metzincins: achievement and perspectives
    Mol Aspects Med29, 329-338. PubMed  Europe PubMed DOI  I
  149. Zhang,Y., Bai,X.T., Zhu,K.Y., Jin,Y., Deng,M., Le,H.Y., Fu,Y.F., Chen,Y., Zhu,J., Look,A.T., Kanki,J., Chen,Z., Chen,S.J. and Liu,T.X.
    In vivo interstitial migration of primitive macrophages mediated by JNK-matrix metalloproteinase 13 signaling in response to acute injury
    J Immunol181, 2155-2164. PubMed  Europe PubMed
    150. 2007
  150. Danfelter,M., Onnerfjord,P. and Heinegard,D.
    Fragmentation of proteins in cartilage treated with interleukin-1: specific cleavage of type IX collagen by matrix metalloproteinase 13 releases the NC4 domain
    J Biol Chem282, 36933-36941. PubMed  Europe PubMed DOI  P
  151. Freeman-Cook,K.D., Reiter,L.A., Noe,M.C., Antipas,A.S., Danley,D.E., Datta,K., Downs,J.T., Eisenbeis,S., Eskra,J.D., Garmene,D.J., Greer,E.M., Griffiths,R.J., Guzman,R., Hardink,J.R., Janat,F., Jones,C.S., Martinelli,G.J., Mitchell,P.G., Laird,E.R., Liras,J.L., Lopresti-Morrow,L.L., Pandit,J., Reilly,U.D., Robertson,D., Vaughn-Bowser,M.L., Wolf-Gouviea,L.A. and Yocum,S.A.
    Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13
    Bioorg Med Chem Lett17, 6529-6534. PubMed  Europe PubMed DOI  I
  152. Hillegass,J.M., Villano,C.M., Cooper,K.R. and White,L.A.
    Matrix metalloproteinase-13 is required for zebrafish (Danio rerio) development and is a target for glucocorticoids
    Toxicol Sci100, 168-179. PubMed  Europe PubMed DOI
  153. Iliopoulos,D., Malizos,K.N. and Tsezou,A.
    Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention
    Ann Rheum Dis66, 1616-1621. PubMed  Europe PubMed DOI
  154. Johnson,A.R., Pavlovsky,A.G., Ortwine,D.F., Prior,F., Man,C.F., Bornemeier,D.A., Banotai,C.A., Mueller,W.T., McConnell,P., Yan,C., Baragi,V., Lesch,C., Roark,W.H., Wilson,M., Datta,K., Guzman,R., Han,H.K. and Dyer,R.D.
    Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects
    J Biol Chem282, 27781-27791. PubMed  Europe PubMed DOI  S  I
  155. [YEAR:23-3-2007]Kosaki,N., Takaishi,H., Kamekura,S., Kimura,T., Okada,Y., Minqi,L., Amizuka,N., Chung,U.I., Nakamura,K., Kawaguchi,H., Toyama,Y. and D'Armiento,J.
    Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice
    Biochem Biophys Res Commun354, 846-851. PubMed  Europe PubMed DOI  K
  156. Maskos,K., Lang,R., Tschesche,H. and Bode,W.
    Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2
    J Mol Biol366, 1222-1231. PubMed  Europe PubMed DOI  S
  157. Samuel,S., Beifuss,K.K. and Bernstein,L.R.
    YB-1 binds to the MMP-13 promoter sequence and represses MMP-13 transactivation via the AP-1 site
    Biochim Biophys Acta1769, 525-531. PubMed  Europe PubMed DOI
  158. Toriseva,M.J., Ala-aho,R., Karvinen,J., Baker,A.H., Marjomaki,V.S., Heino,J. and Kahari,V.M.
    Collagenase-3 (MMP-13) enhances remodeling of three-dimensional collagen and promotes survival of human skin fibroblasts
    J Invest Dermatol127, 49-59. PubMed  Europe PubMed DOI
    159. 2006
  159. Hernandez,M., Valenzuela,M.A., Lopez-Otin,C., Alvarez,J., Lopez,J.M., Vernal,R. and Gamonal,J.
    Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity
    J Periodontol77, 1863-1870. PubMed  Europe PubMed DOI
  160. [YEAR:27-3-2006]Kohno,T., Hochigai,H., Yamashita,E., Tsukihara,T. and Kanaoka,M.
    Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453
    Biochem Biophys Res Commun344, 315-322. PubMed  Europe PubMed DOI  S  I
  161. Minond,D., Lauer-Fields,J.L., Cudic,M., Overall,C.M., Pei,D., Brew,K., Visse,R., Nagase,H. and Fields,G.B.
    The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity
    J Biol Chem281, 38302-38313. PubMed  Europe PubMed DOI
  162. Monfort,J., Tardif,G., Reboul,P., Mineau,F., Roughley,P., Pelletier,J.P. and Martel-Pelletier,J.
    Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site
    Arthritis Res Ther8, R26-R26. PubMed  Europe PubMed DOI
    163. 2005
  163. [YEAR:1-4-2005]Blagg,J.A., Noe,M.C., Wolf-Gouveia,L.A., Reiter,L.A., Laird,E.R., Chang,S.P., Danley,D.E., Downs,J.T., Elliott,N.C., Eskra,J.D., Griffiths,R.J., Hardink,J.R., Haugeto,A.I., Jones,C.S., Liras,J.L., Lopresti-Morrow,L.L., Mitchell,P.G., Pandit,J., Robinson,R.P., Subramanyam,C., Vaughn-Bowser,M.L. and Yocum,S.A.
    Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14
    Bioorg Med Chem Lett15, 1807-1810. PubMed  Europe PubMed DOI  I
  164. Engel,C.K., Pirard,B., Schimanski,S., Kirsch,R., Habermann,J., Klingler,O., Schlotte,V., Weithmann,K.U. and Wendt,K.U.
    Structural basis for the highly selective inhibition of MMP-13
    Chem Biol12, 181-189. PubMed  Europe PubMed DOI  I
  165. [YEAR:15-9-2005]Kennedy,A.M., Inada,M., Krane,S.M., Christie,P.T., Harding,B., Lopez-Otin,C., Sanchez,L.M., Pannett,A.A., Dearlove,A., Hartley,C., Byrne,M.H., Reed,A.A., Nesbit,M.A., Whyte,M.P. and Thakker,R.V.
    MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMDMO)
    J Clin Invest115, 2832-2842. PubMed  Europe PubMed DOI  M
  166. [YEAR:15-2-2005]Kim,S.H., Pudzianowski,A.T., Leavitt,K.J., Barbosa,J., McDonnell,P.A., Metzler,W.J., Rankin,B.M., Liu,R., Vaccaro,W. and Pitts,W.
    Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)
    Bioorg Med Chem Lett15, 1101-1106. PubMed  Europe PubMed DOI  I
  167. [YEAR:6-9-2005]Li,J., Rush,T.S., III, Li,W., DeVincentis,D., Du,X., Hu,Y., Thomason,J.R., Xiang,J.S., Skotnicki,J.S., Tam,S., Cunningham,K.M., Chockalingam,P.S., Morris,E.A. and Levin,J.I.
    Synthesis and SAR of highly selective MMP-13 inhibitors
    Bioorg Med Chem Lett15, 4961-4966. PubMed  Europe PubMed DOI  I
  168. [YEAR:8-3-2005]Lopez-Rivera,E., Lizarbe,T.R., Martinez-Moreno,M., Lopez-Novoa,J.M., Rodriguez-Barbero,A., Rodrigo,J., Fernandez,A.P., Alvarez-Barrientos,A., Lamas,S. and Zaragoza,C.
    Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration
    Proc Natl Acad Sci U S A102, 3685-3690. PubMed  Europe PubMed DOI
  169. [YEAR:15-7-2005]Noe,M.C., Natarajan,V., Snow,S.L., Wolf-Gouveia,L.A., Mitchell,P.G., Lopresti-Morrow,L., Reeves,L.M., Yocum,S.A., Otterness,I., Bliven,M.A., Carty,T.J., Barberia,J.T., Sweeney,F.J., Liras,J.L. and Vaughn,M.
    Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13
    Bioorg Med Chem Lett15, 3385-3388. PubMed  Europe PubMed DOI  I
  170. [YEAR:2-6-2005]Noe,M.C., Natarajan,V., Snow,S.L., Mitchell,P.G., Lopresti-Morrow,L., Reeves,L.M., Yocum,S.A., Carty,T.J., Barberia,J.A., Sweeney,F.J., Liras,J.L., Vaughn,M., Hardink,J.R., Hawkins,J.M. and Tokar,C.
    Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13
    Bioorg Med Chem Lett15, 2808-2811. PubMed  Europe PubMed DOI  I
  171. Wasserman,Z.R.
    Making a new turn in matrix metalloprotease inhibition
    Chem Biol12, 143-144. PubMed  Europe PubMed DOI  S  I
  172. [YEAR:5-7-2005]Wu,J., Rush,T.S., III, Hotchandani,R., Du,X., Geck,M., Collins,E., Xu,Z.B., Skotnicki,J., Levin,J.I. and Lovering,F.E.
    Identification of potent and selective MMP-13 inhibitors
    Bioorg Med Chem Lett15, 4105-4109. PubMed  Europe PubMed DOI  I
    173. 2004
  173. [YEAR:19-4-2004]Ala-aho,R., Ahonen,M., George,S.J., Heikkila,J., Grenman,R., Kallajoki,M. and Kahari,V.M.
    Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo
    Oncogene23, 5111-5123. PubMed  Europe PubMed DOI
  174. Henriet,P. and Eeckhout,Y.
    Collagenase 3
    [ISSN:0-12-079610-4]2, 486-494.  V
  175. [YEAR:7-12-2004]Inada,M., Wang,Y., Byrne,M.H., Rahman,M.U., Miyaura,C., Lopez-Otin,C. and Krane,S.M.
    Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification
    Proc Natl Acad Sci U S A101, 17192-17197. PubMed  Europe PubMed DOI  K
  176. Joronen,K., Ala-aho,R., Majuri,M.L., Alenius,H., Kahari,V.M. and Vuorio,E.
    Adenovirus mediated intra-articular expression of collagenase-3 (MMP-13) induces inflammatory arthritis in mice
    Ann Rheum Dis63, 656-664. PubMed  Europe PubMed DOI
  177. [YEAR:20-9-2004]Noe,M.C., Snow,S.L., Wolf-Gouveia,L.A., Mitchell,P.G., Lopresti-Morrow,L., Reeves,L.M., Yocum,S.A., Liras,J.L. and Vaughn,M.
    3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase
    Bioorg Med Chem Lett14, 4727-4730. PubMed  Europe PubMed DOI  I
  178. Stickens,D., Behonick,D.J., Ortega,N., Heyer,B., Hartenstein,B., Yu,Y., Fosang,A.J., Schorpp-Kistner,M., Angel,P. and Werb,Z.
    Altered endochondral bone development in matrix metalloproteinase 13-deficient mice
    Development131, 5883-5895. PubMed  Europe PubMed DOI  K
  179. Tardif,G., Reboul,P., Pelletier,J.P. and Martel-Pelletier,J.
    Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3)
    Mod Rheumatol14, 197-204. PubMed  Europe PubMed DOI  V
  180. [YEAR:5-4-2004]Zijlstra,A., Aimes,R.T., Zhu,D., Regazzoni,K., Kupriyanova,T., Seandel,M., Deryugina,E.I. and Quigley,J.P.
    Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3)
    J Biol Chem279, 27633-27645. PubMed  Europe PubMed DOI
    181. 2003
  181. Skotnicki,J.S., DiGrandi,M.J. and Levin,J.I.
    Design strategies for the identification of MMP-13 and TACE inhibitors
    Curr Opin Drug Discov Devel6, 742-759. PubMed  Europe PubMed  I
  182. Tardif,G., Dupuis,M., Reboul,P., Geng,C.S., Pelletier,J.P., Ranger,P. and Martel-Pelletier,J.
    Identification and differential expression of human collagenase-3 mRNA species derived from internal deletion, alternative splicing, and different polyadenylation and transcription initiation sites
    Osteoarthritis Cartilage11, 524-537. PubMed  Europe PubMed DOI  R
    183. 2002
  183. [YEAR:20-1-2002]Ala-aho,R., Johansson,N., Baker,A.H. and Kahari,V.M.
    Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells
    Int J Cancer97, 283-289. PubMed  Europe PubMed DOI  I
  184. [YEAR:20-3-2002]Campbell,S.E., Sood,A., Argyle,D.J., Nasir,L., Argyle,S.A. and Bennett,D.
    The cloning and functional analysis of canine matrix metalloproteinase-13 gene promoter
    Gene286, 233-240. PubMed  Europe PubMed DOI
  185. Fukui,N., McAlinden,A., Zhu,Y., Crouch,E., Broekelmann,T.J., Mecham,R.P. and Sandell,L.J.
    Processing of type II procollagen amino propeptide by matrix metalloproteinases
    J Biol Chem277, 2193-2201. PubMed  Europe PubMed DOI
  186. [YEAR:4-12-2002]Knauper,V., Bailey,L., Worley,J.R., Soloway,P., Patterson,M.L. and Murphy,G.
    Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13
    FEBS Lett532, 127-130. PubMed  Europe PubMed DOI
  187. Leeman,M.F., Curran,S. and Murray,G.I.
    The structure, regulation, and function of human matrix metalloproteinase-13
    Crit Rev Biochem Mol Biol37, 149-166. PubMed  Europe PubMed DOI
  188. Murphy,G., Knauper,V., Atkinson,S., Butler,G., English,W., Hutton,M., Stracke,J. and Clark,I.
    Matrix metalloproteinases in arthritic disease
    Arthritis Res4 Suppl 3, S39-S49. PubMed  Europe PubMed
  189. Wu,C.W., Tchetina,E.V., Mwale,F., Hasty,K., Pidoux,I., Reiner,A., Chen,J., Van Wart,H.E. and Poole,A.R.
    Proteolysis involving matrix metalloproteinase 13 (collagenase-3) is required for chondrocyte differentiation that is associated with matrix mineralization
    J Bone Miner Res17, 639-651. PubMed  Europe PubMed DOI
    190. 2001
  190. [YEAR:6-4-2001]D'Angelo,M., Billings,P.C., Pacifici,M., Leboy,P.S. and Kirsch,T.
    Authentic matrix vesicles contain active metalloproteases (MMP). A role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-beta
    J Biol Chem276, 11347-11353. PubMed  Europe PubMed DOI
  191. Natchus,M.G., Bookland,R.G., Laufersweiler,M.J., Pikul,S., Almstead,N.G., De,B., Janusz,M.J., Hsieh,L.C., Gu,F., Pokross,M.E., Patel,V.S., Garver,S.M., Peng,S.X., Branch,T.M., King,S.L., Baker,T.R., Foltz,D.J. and Mieling,G.E.
    Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines
    J Med Chem44, 1060-1071. PubMed  Europe PubMed DOI  I
  192. Neuhold,L.A., Killar,L., Zhao,W., Sung,M.L., Warner,L., Kulik,J., Turner,J., Wu,W., Billinghurst,C., Meijers,T., Poole,A.R., Babij,P. and DeGennaro,L.J.
    Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice
    J Clin Invest107, 35-44. PubMed  Europe PubMed DOI
  193. [YEAR:1-6-2001]Yu,W.H. and Woessner,J.F., Jr.
    Heparin-enhanced zymographic detection of matrilysin and collagenases
    Anal Biochem293, 38-42. PubMed  Europe PubMed DOI  A  L
    194. 2000
  194. [YEAR:6-10-2000]Deng,S.J., Bickett,D.M., Mitchell,J.L., Lambert,M.H., Blackburn,R.K., Carter,H.L., III, Neugebauer,J., Pahel,G., Weiner,M.P. and Moss,M.L.
    Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library
    J Biol Chem275, 31422-31427. PubMed  Europe PubMed DOI  P
  195. Hardern,I.M., Knauper,V., Ernill,R.J., Taylor,I.W.F., Cooper,K.L. and Abbott,W.M.
    An analysis of two refolding routes for a C-terminally truncated human collagenase-3 expressed in Escherichia coli
    Protein Expr Purif19, 246-252. PubMed  Europe PubMed DOI  E
  196. [YEAR:22-9-2000]Moy,F.J., Chanda,P.K., Chen,J.M., Cosmi,S., Edris,W., Levin,J.I. and Powers,R.
    High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor
    J Mol Biol302, 671-689. PubMed  Europe PubMed DOI  S  I
  197. Otterness,I.G., Bliven,M.L., Eskra,J.D., te Koppele,J.M., Stukenbrok,H.A. and Milici,A.J.
    Cartilage damage after intraarticular exposure to collagenase 3
    Osteoarthritis Cartilage8, 366-373. PubMed  Europe PubMed DOI
  198. [YEAR:15-2-2000]Pendas,A.M., Uria,J.A., Jimenez,M.G., Balbin,M., Freije,J.P. and Lopez-Otin,C.
    An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies
    Clin Chim Acta291, 137-155. PubMed  Europe PubMed DOI
  199. [YEAR:11-8-2000]Zhang,X., Gonnella,N.C., Koehn,J., Pathak,N., Ganu,V., Melton,R., Parker,D., Hu,S.I. and Nam,K.Y.
    Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: Binding comparison with stromelysin-1 and collagenase-1
    J Mol Biol301, 513-524. PubMed  Europe PubMed DOI  S  I
    200. 1999
  200. [YEAR:1-10-1999]Botos,I., Meyer,E., Swanson,S.M., Lemaitre,V., Eeckhout,Y. and Meyer,E.F.
    Structure of recombinant mouse collagenase-3 (MMP-13)
    J Mol Biol292, 837-844. PubMed  Europe PubMed DOI  S
  201. Jimenez,M.J., Balbin,M., Lopez,J.M., Alvarez,J., Komori,T. and Lopez-Otin,C.
    Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation
    Mol Cell Biol19, 4431-4442. PubMed  Europe PubMed
  202. Johansson,N., Vaalamo,M., Grenman,S., Hietanen,S., Klemi,P., Saarialho-Kere,U. and Kahari,V.M.
    Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas
    Am J Pathol154, 469-480. PubMed  Europe PubMed DOI
  203. Lovejoy,B., Welch,A.R., Carr,S., Luong,C., Broka,C., Hendricks,R.T., Campbell,J.A., Walker,K.A., Martin,R., Van Wart,H. and Browner,M.F.
    Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors
    Nat Struct Biol6, 217-221. PubMed  Europe PubMed DOI  S  I
    204. 1998
  204. Kozaci,L.D., Brown,C.J., Adcocks,C., Galloway,A., Hollander,A.P. and Buttle,D.J.
    Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown
    J Clin Pathol Mol Pathol51, 282-286. PubMed  Europe PubMed
  205. Pathak,N., Hu,S.I. and Koehn,J.A.
    The expression, refolding, and purification of the catalytic domain of human collagenase-3 (MMP-13)
    Protein Expr Purif14, 283-288. PubMed  Europe PubMed DOI
  206. [YEAR:24-4-1998]Selvamurugan,N., Chou,W.Y., Pearman,A.T., Pulumati,M.R. and Partridge,N.C.
    Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence
    J Biol Chem273, 10647-10657. PubMed  Europe PubMed DOI
  207. Uitto,V.J., Airola,K., Vaalamo,M., Johansson,N., Putnins,E.E., Firth,J.D., Salonen,J., Lopez-Otin,C., Saarialho-Kere,U. and Kahari,V.M.
    Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation
    Am J Pathol152, 1489-1499. PubMed  Europe PubMed
  208. [YEAR:17-4-1998]Uria,J.A., Jimenez,M.G., Balbin,M., Freije,J.M. and Lopez-Otin,C.
    Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts
    J Biol Chem273, 9769-9777. PubMed  Europe PubMed DOI
  209. [YEAR:1-4-1998]Vincenti,M.P., Coon,C.I., Mengshol,J.A., Yocum,S., Mitchell,P. and Brinckerhoff,C.E.
    Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1)
    Biochem J331, 341-346. PubMed  Europe PubMed
  210. Willmroth,F., Peter,H.H. and Conca,W.
    A matrix metalloproteinase gene expressed in human T lymphocytes is identical with collagenase 3 from breast carcinomas
    Immunobiology198, 375-384. PubMed  Europe PubMed DOI
    211. 1997
  211. Airola,K., Johansson,N., Kariniemi,A.L., Kahari,V.M. and Saarialho-Kere,U.K.
    Human collagenase-3 is expressed in malignant squamous epithelium of the skin
    J Invest Dermatol109, 225-231. PubMed  Europe PubMed
  212. Johansson,N., Saarialho-Kere,U., Airola,K., Herva,R., Nissinen,L., Westermarck,J., Vuorio,E., Heino,J. and Kahari,V.M.
    Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development
    Dev Dyn208, 387-397. PubMed  Europe PubMed DOI
  213. Knauper,V., Smith,B., Lopez-Otin,C. and Murphy,G.
    Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13)
    Eur J Biochem248, 369-373. PubMed  Europe PubMed
  214. Knauper,V., Cowell,S., Smith,B., Lopez-Otin,C., O'Shea,M., Morris,H., Zardi,L. and Murphy,G.
    The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction
    J Biol Chem272, 7608-7616. PubMed  Europe PubMed DOI
  215. Lemaitre,V., Jungbluth,A. and Eeckhout,Y.
    The recombinant catalytic domain of mouse collagenase-3 depolymerizes type I collagen by cleaving its aminotelopeptides
    Biochem Biophys Res Commun230, 202-205. PubMed  Europe PubMed DOI
    216. 1996
  216. Gomis-Ruth,F.X., Gohlke,U., Betz,M., Knauper,V., Murphy,G., Lopez-Otin,C. and Bode,W.
    The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain
    J Mol Biol264, 556-566. PubMed  Europe PubMed DOI
  217. Knauper,V., Will,H., Lopez-Otin,C., Smith,B., Atkinson,S.J., Stanton,H., Hembry,R.M. and Murphy,G.
    Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme
    J Biol Chem271, 17124-17131. PubMed  Europe PubMed DOI
  218. Knauper,V., Lopez-Otin,C., Smith,B., Knight,G. and Murphy,G.
    Biochemical characterization of human collagenase-3
    J Biol Chem271, 1544-1550. PubMed  Europe PubMed DOI
  219. [YEAR:8-11-1996]Krane,S.M., Byrne,M.H., Lemaitre,V., Henriet,P., Jeffrey,J.J., Witter,J.P., Liu,X., Wu,H., Jaenisch,R. and Eeckhout,Y.
    Different collagenase gene products have different roles in degradation of type I collagen
    J Biol Chem271, 28509-28515. PubMed  Europe PubMed DOI
  220. Mitchell,P.G., Magna,H.A., Reeves,L.M., Lopresti-Morrow,L.L., Yocum,S.A., Rosner,P.J., Geoghegan,K.F. and Hambor,J.E.
    Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
    J Clin Invest97, 761-768. PubMed  Europe PubMed DOI
  221. Reboul,P., Pelletier,J.P., Tardif,G., Cloutier,J.M. and Martel-Pelletier,J.
    The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis
    J Clin Invest97, 2011-2019. PubMed  Europe PubMed DOI
    222. 1995
  222. Pendas,A.M., Matilla,T., Estivill,X. and Lopez-Otin,C.
    The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family
    Genomics26, 615-618. PubMed  Europe PubMed DOI
    223. 1994
  223. [YEAR:17-6-1994]Freije,J.M., Diez-Itza,I., Balbin,M., Sanchez,L.M., Blasco,R., Tolivia,J. and Lopez-Otin,C.
    Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
    J Biol Chem269, 16766-16773. PubMed  Europe PubMed
    224. 1992
  224. Henriet,P., Rousseau,G.G. and Eeckhout,Y.
    Cloning and sequencing of mouse collagenase cDNA. Divergence of mouse and rat collagenases from the other mammalian collagenases
    FEBS Lett310, 175-178. PubMed  Europe PubMed DOI
    225. 1990
  225. Quinn,C.O., Scott,D.K., Brinckerhoff,C.E., Matrisian,L.M., Jeffrey,J.J. and Partridge,N.C.
    Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells
    J Biol Chem265, 22342-22347. PubMed  Europe PubMed
    226. 1985
  226. Welgus,H.G., Grant,G.A., Sacchettini,J.C., Roswit,W.T. and Jeffrey,J.J.
    The gelatinolytic activity of rat uterus collagenase
    J Biol Chem260, 13601-13606. PubMed  Europe PubMed
    227. 1983
  227. [YEAR:10-12-1983]Welgus,H.G., Kobayashi,D.K. and Jeffrey,J.J.
    The collagen substrate specificity of rat uterus collagenase
    J Biol Chem258, 14162-14165. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use